Augmenting DNA Damage by Chemotherapy With CDK7 Inhibition to Disrupt PARP Expression in Cholangiocarcinoma

Article Type
Article
Changed
Tue, 09/09/2025 - 09:56
Author(s)
Jeremy Kratz, MD
Austin Stram
Maria Guadalupe Martinez
Eleanor Reidl
Lauryn Flannagan, MD
Shahadat Hossan, MD
Issue
Federal Practitioner - 42(9)s
Publications
AVAHO
Federal Practitioner
Topics
Liver Disease
Cancer
Oncology
Conference Coverage
Page Number
S40-S41
Sections
Original Research
Conference Coverage
Author(s)
Jeremy Kratz, MD
Austin Stram
Maria Guadalupe Martinez
Eleanor Reidl
Lauryn Flannagan, MD
Shahadat Hossan, MD
Author(s)
Jeremy Kratz, MD
Austin Stram
Maria Guadalupe Martinez
Eleanor Reidl
Lauryn Flannagan, MD
Shahadat Hossan, MD
Issue
Federal Practitioner - 42(9)s
Issue
Federal Practitioner - 42(9)s
Page Number
S40-S41
Page Number
S40-S41
Publications
AVAHO
Federal Practitioner
Publications
AVAHO
Federal Practitioner
Topics
Liver Disease
Cancer
Oncology
Conference Coverage
Article Type
Article
Sections
Original Research
Conference Coverage
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Research
Gate On Date
Mon, 09/08/2025 - 14:45
Un-Gate On Date
Mon, 09/08/2025 - 14:45
Use ProPublica
CFC Schedule Remove Status
Mon, 09/08/2025 - 14:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date
Mon, 09/08/2025 - 14:45
Subscribe to Lauryn Flannagan, MD